Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Submits HPV Assay Application to FDA

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe said after the close of the market Monday that it has submitted a Premarket Approval Application with the US Food and Drug Administration for its Aptima human papillomavirus assay.

The San Diego-based molecular diagnostics firm said that the new nucleic acid test can detect high-risk HPV infections that are associated with cervical cancer and precancerous lesions. Specifically, the Aptima HPV assay detects 14 high-risk HPV types that are associated with cervical cancer. It also can detect messenger RNA from two viral oncogenes, E6 and E7, which are more prevalent in the severe cervical lesions likely to progress to cervical cancer, the firm said.

If the test is cleared by FDA, it will run on Gen-Probe's Tigris molecular diagnostics instrument. It would compete with FDA-cleared molecular tests sold by Qiagen and Hologic.

"From a business perspective, this regulatory submission represents the last of five we have completed in the United States this year," Gen-Probe President and CEO Carl Hull said in a statement. "When approved, we expect these new products to start an important new sales growth cycle for the company."

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.